Dr. Kayla Bean
Kayla completed her B.S. at University of Tennessee Knoxville in Microbiology and attended Georgia State University for MS and PhD degrees in Applied and Environmental Microbiology. She did her postdoctoral work in Cell Line Engineering at Elanco before joining AGC Biologics in 2021. She is currently based in Bothell, WA as the AGC Biologics R&D […]
Dr. Michelle Sabourin
Dr. Michelle Sabourin is a cell and molecular biologist with over 15 years of industry experience in cell line development (CLD). Prior to Cytiva/GE Healthcare, she worked in R&D for Gibco where she developed products for the CLD space. In her current role, Michelle is responsible for CLD projects as part of Cytiva’s Cell Culture […]
Dr. Séverine Fagète
Séverine is the Vice President of Mammalian Cell Line Development (CLD) at KBI Biopharma’s Geneva Facility. Prior to the operational consolidation with KBI, Séverine held multiple leadership roles with escalating responsibilities at Selexis. She brings nearly two decades of experience in the pharmaceutical industry, and deep expertise in early drug discovery, antibody engineering (bispecifics), stable […]
Dr. Lena Tholen
Dr. Lena Tholen holds a Diploma in Biotechnology from the Technical University of Berlin (2013) and gained research experience at KTH, focusing on high cell density perfusion processes with CHO cells. She earned a PhD (2014-2017) for her work on CHO cell-based cell-free systems in collaboration with Fraunhofer IZ-BB. Since 2019, she has worked as […]
Discussion Panel
Challenges in Cell Line Development The panel discussion will feature distinguished experts in biotechnology and life sciences examining the intricate challenges associated with cell line development. The session will address key issues, including time-to-market considerations, optimization of clone selection, assurance of product consistency, and compliance with regulatory standards. Additionally, topics such as data management and […]
